UBS O'Connor’s C.H. Robinson CHRW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$2.92M Sell
18,170
-53,630
-75% -$7.92M 0.08% 80
2025
Q3
$9.51M Buy
+71,800
New +$8.42M 0.28% 41
2017
Q4
Sell
-25,400
Closed -$1.93M 305
2017
Q3
$1.93M Buy
+25,400
New +$1.76M 0.03% 259
2016
Q1
Sell
-210,882
Closed -$13.1M 456
2015
Q4
$13.1M Buy
+210,882
New +$14.2M 0.12% 158
2015
Q2
Sell
-92,644
Closed -$6.78M 802
2015
Q1
$6.78M Buy
+92,644
New +$6.77M 0.07% 257

Other funds holding CHRW

UBS O'Connor's CHRW Position: Q4 2025 in Review

UBS O'Connor reduced its C.H. Robinson (CHRW) stake by 75% in Q4 2025, selling an estimated $7.92M and leaving 18,170 shares worth $2.92M. The position accounts for 0.08% of the portfolio, ranked #80.

UBS O'Connor first reported a position in CHRW in Q1 2015 and has held it in 5 quarters since. The position peaked at $13.1M in Q4 2015. 819 funds tracked by Wall St. Rank hold CHRW as of Q4 2025.

  • UBS O'Connor held 18,170 shares of C.H. Robinson worth $2.92M as of Q4 2025.
  • UBS O'Connor sold 53,630 C.H. Robinson shares in Q4 2025, an estimated $7.92M.
  • C.H. Robinson made up 0.08% of UBS O'Connor's portfolio in Q4 2025, its #80 holding.
  • UBS O'Connor first reported a position in C.H. Robinson in Q1 2015 and has held it in 5 quarters since.
  • UBS O'Connor's C.H. Robinson position peaked at $13.1M in Q4 2015.
  • 819 funds tracked by Wall St. Rank held C.H. Robinson as of Q4 2025.

Based on UBS O'Connor's 13F filing for Q4 2025, filed 13 Feb 2026.